South Africa to ramp up vaccinations as foot-and-mouth disease spreads
June 6 (Reuters) - South Africa is building up vaccine stocks and expanding inoculations to fight a worsening foot-and-mouth disease outbreak, the agriculture ministry said, as the country faces threats to beef supplies.
Foot-and-mouth disease is a highly contagious, viral infection of cloven-hoofed animals that may also affect other species. Flare-ups have been reported over the past several months in five of South Africa's nine provinces, with KwaZulu- Natal being the worst affected.
This week, Karan Beef, opens new tab, which operates the country's largest feedlot and one of the world's biggest, reported an outbreak at its facility in Heidelberg, about 50 kilometres southeast of Johannesburg. The quarantine imposed on the feedlot, which slaughters about 2,000 cattle daily, could impact beef supplies.
The government has ordered over 900,000 doses of foot-and-mouth disease vaccines with the first batch expected to
arrive next week, the agriculture ministry said in a statement late on Thursday.
"These plans are not only about responding to outbreaks, but also about building permanent infrastructure to manage future risks," it said.
There are growing calls by some cattle producers to declare a "state of disaster" and protect the industry from financial losses. Invoking disaster law gives the government additional powers to intervene in a crisis.
The foot-and-mouth disease outbreaks have resulted in South African beef and related products being banned in markets such as China, Namibia and Zimbabwe.
South Africa's livestock sector is also recovering from its worst avian flu outbreak, which destroyed a third of the national chicken flock in 2023.
On Thursday, the government announced the first ever mass vaccination of poultry to prevent a repeat outbreak of high-pathogenic avian influenza (HPAI), a bird flu that spreads rapidly in an infected flock, causing a high death rate.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
a day ago
- The Guardian
Texas measles outbreak ‘on the decline', officials say
The measles outbreak that began sweeping across west Texas earlier this year is showing signs of slowing, according to the state's health services department. For the first time since the outbreak was first reported in January, no new cases were added in the department's latest update. The total case count remains at 742, a figure that has been updated biweekly by state officials. 'Thankfully, this large outbreak that we've been tracking in west Texas does seem to be on the decline,' Dr Jennifer Shuford, commissioner of the the state health services department told the Texas Standard, though she warned that 'it just takes one person to get into an under-vaccinated community to cause another outbreak'. Measles had been declared eliminated from the US in 2000, but it has been spreading in undervaccinated communities. Though most of Texas's outbreak has been concentrated in its western part, sporadic cases have appeared elsewhere in the state. Some of these cases have been linked to international travel while others remain under investigation due to unclear origins. The majority of cases have been reported in Gaines county, home to a Mennonite community with historically low childhood immunization rates. Two children from the affected region, both unvaccinated and with no known pre-existing conditions, have died due to the disease. The earlier of those deaths was the first in the US from measles since 2015. According to the latest Texas state health services department figures, fewer than 10 of the confirmed cases are currently considered infectious – which is defined as individuals within four days before or after the appearance of the measles rash. Since January, 94 people have been hospitalized. The state health agency has identified seven counties with ongoing measles transmission: Cochran, Dawson, Gaines, Lamar, Lubbock, Terry and Yoakum. The agency says it continues to work closely with local health officials to monitor and contain the spread. Shuford says that the department has struggled to adequately encourage community members to get vaccinated, explaining that the state health service department is 'really trying to strengthen our messaging at all times and so that we already have a relationship with different communities'. She added that 'vaccines are just such an instrumental way for us to maintain a healthy society that can be productive'.
Daily Mail
a day ago
- Daily Mail
Subtle warning signs of 'silent disease' 16m Americans are living with and don't know
Nearly 16 million people have the most deadly type of liver disease, yet 80 percent of them have no idea. About five percent of adults worldwide have metabolic dysfunction-associated steatohepatitis (MASH) a serious liver condition caused by fat buildup, inflammation, and scarring. It's the most dangerous type of fatty liver disease MASH triggers liver scarring, which can progress to cirrhosis, and significantly increases the risk of heart disease, chronic kidney disease, and liver cancer. Just one in five Americans with the condition are actually diagnosed. Most patients do not experience symptoms until the damage is irreversible, making it a 'silent disease'. However, as the condition progresses, individuals may experience fatigue, pain or discomfort in the upper right belly, unexplained weight loss, weakness, and in some cases, jaundice (yellowing of the skin and eyes). A coalition of researchers from the US, Europe, and South Africa said that MASH-related liver failure and other complications, including deaths, are becoming more severe and common. The scientists behind the report, published in The Lancet Regional Health Europe, are calling for a doubling in MASH diagnosis rates from the 2022 level, about 13 percent (the current rate is just under 20 percent). They estimated that about 2.6 million people in the US, UK, Germany, and France have been diagnosed with MASH. But if testing were adequately improved and scaled up to become more accessible and commonplace, that figure could balloon to 6.1 million. People with type 2 diabetes, obesity, and heart disease should be prioritized for blood work and other screening tests, which will need to skyrocket from about two million to 36 million. Follow-up testing also needs to jump by nearly 1,300 percent to meet patient needs, and in more settings than liver clinics, such as family doctors' offices, and with diabetes and heart doctors. People with diabetes are especially prone to liver damage leading to MASH. Around 30 to 60 percent of diabetics also have MASH. Obesity is another leading risk factor, with estimates suggesting that 75 percent of overweight people and 90 percent with obesity will develop the condition. People with MASH also have a tripled risk of also developing heart disease, including coronary artery disease, stroke, and heart failure, compared to people without the condition. MASH diagnosis is poised for a major shift, mirroring past breakthroughs in chronic disease management. With new treatments approved and others on the horizon, the focus now turns to fixing systemic roadblocks. Currently, limited access to non-invasive tests and reliance on specialists leave most cases undetected until late stages. MASH arises from a cascade of liver damage typically linked to a buildup of fat in the liver, which triggers inflammation that damages liver cells and activates scar-forming cells. What was once healthy liver tissue becomes stiff, progressively crippling the liver's ability to detoxify blood. Though this is often painless until the damage becomes too severe to be reversed. If caught early, people can live normal lifespans with MASH. Lifestyle changes - eating a healthier diet, exercising regularly, and losing between five and 10 percent of one's body weight - can slow down the progression of MASH and repair some of the damage. Doctors may prescribe resmetirom, the first FDA-approved medication for MASH, to work hand-in-hand with those lifestyle changes. But severe damage can cause deadly conditions that cut a person's life drastically short. 'Each late-stage MASH diagnosis represents a missed opportunity for earlier intervention to prevent disease progression, threatening worse [liver] and [non-liver] outcomes for people living with the condition and greater costs for individuals, health systems, and societies,' researchers told a Barcelona medical conference this week. The solution requires concrete changes from moving diagnostics to implementing automated tools in electronic records. The researchers said that success in improving diagnostics goes beyond devising better tests. A fundamental reworking of methods of care is needed that catches at-risk patients before irreversible damage occurs. 'Paradigm shifts do not occur in a vacuum, but arise when leaps in science, technology, and innovation are coupled with changes in perception and understanding within a community,' they said. 'A confluence of factors in 2024 and expected drug approvals in many European countries in 2025 point to a near term tipping point for MASH diagnoses; nonetheless, focused and sustained efforts are needed to turn such opportunities into reality.'
BBC News
a day ago
- BBC News
Gonorrhoea vaccinations to start in Northern Ireland in August
The Department of Health has said a targeted vaccination programme against gonorrhoea has been approved across Northern Ireland. Eligible patients will be offered the vaccine from August 2025, the department said. Those eligible include gay and bisexual men who have a recent history of multiple sexual partners or have recently had a sexually transmitted infection (STI). Gonorrhoea is now the most prevalent STI diagnosed in sexual health clinics in Northern Ireland, according to the Public Health Agency (PHA). England will also begin its vaccination roll out in August this vaccine roll out will also focus mainly on gay and bisexual men with a history of multiple sexual partners or an was given by the Joint Committee on Vaccination and Immunisation (JCVI) in November 2023, which recommended roll out of the vaccine following an upsurge in gonorrhoea Minister Mike Nesbitt said the launch of the vaccine programme is "important and very timely for Northern Ireland's public health". He added that by targeting those "most at risk", there is an "opportunity to curb the spread and reduce transmission rates". The vaccine is an existing one for meningococcal B disease, called 4CMenB. The UK Health Security Agency (UKHSA) research shows that those who receive the jab could be protected from the STI by up to 40% and it could help tackle levels of antibiotic-resistant strains of the disease. Record number of gonorrhoea cases PHA figures for Northern Ireland show that between 2021 and 2022 the number of cases jumped from 652 to 1,606 - the highest number recorded by the were 951 cases in 2019, but that dropped to 455 in 2020, likely due to changes in behaviour and healthcare associated with the Covid 2023, there were 1,561 new cases, accounting for almost a third (28%) of all new STI diagnoses in Northern Ireland. Of those diagnosed, 75% were males and of those 67% were gay, bisexual and men who have sex with does not always have symptoms, but they can include pain, unusual discharge, inflammation of the genitals and infertility. The chief medical officer said the vaccine roll-out will have "significant public health benefits for both those who receive the vaccine, and the wider population".Sir Michael McBride said the programme has "the potential to result in less patients presenting with more complex cases and clusters of gonorrhoea".He encouraged all those eligible to take up the vaccine when offered. What is gonorrhoea? Gonorrhoea is easily passed from person to person through unprotected one in 10 infected men and almost half of infected women do not experience any infection can be passed from a pregnant woman to her baby, and without treatment, can cause permanent blindness for a newborn is not spread by non-sexual contact like is not transmitted through surfaces and materials like toilet seats, towels, cups or you have had successful treatment for gonorrhoea before, you can still catch it NHS.
